爱夜夜性夜夜夜夜夜夜爽-愛妃中文字幕亚洲精品乱码-按摩无码在线观看-暗呦交小-凹凸国产熟-凹凸国产熟女精

dynamic
動態

轉自美聯社:BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch

2025-03-28

Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced on Thursday, March 20 that a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar was gearing up for release.

Yongwei Hu, CEO & Chairman of BON, said “Backed by a robust IP strategy, BON is aggressively pursuing global patent protection. Over the next two years, we plan to lock down approvals across top markets, safeguarding our innovation while positioning ourselves for long-term dominance in the fast-growing metabolic health space. This strategic move not only shields the technology but also primes the business for scalable revenue growth and investor appeal.”

As China pushes its Healthy China 2030 agenda, the health industry is riding a sustained growth wave. According to iiMedia Data, a local authoritative third-party data monitoring institution, the market size of China’s health food products industry in 2023 exceeded 328 billion RMB ($45.5 billion), and is expected to reach 423.7 billion RMB ($58.8 billion) by 2027. Among them, vitamins and dietary supplements (VDS) account for over half of the total market. While China’s VDS spending per capita remains 22% of the U.S. levels, analysts project accelerated demand driven by aging demographics and preventive healthcare trends.

BON is positioning itself at the forefront of this fastest-growing industry. A strategic partnership built on March 9 with China’s agricultural giant Sanzhuliang Group Co., Ltd. signals BON’s ambition to bridge farming and biotech. The collaboration, facilitated by the Listed Companies Division of Commercial Culture Association of China, will focus on biotech innovation, functional food R&D, smart agriculture, industry standards, and more. An expert workstation under the Division was launched at BON’s headquarters to advance digital transformation and promote traditional Chinese medicine globally.

The Company’s recent stock surge underscores investor confidence in its leadership in China’s trillion-dollar functional food market. On Friday, March 14, BON stock skyrocketed over 300%, triggering multiple trading halts. Days later, BON priced a best efforts offering of $12 million, before deducting placement agent fees and other estimated expenses payable by the Company. BON intends to use the net proceeds from this offering for R&D, product expansion, global marketing and other corporate purposes.

As one of the few suppliers of stachyose, an extract from stachy affinis and also a prebiotic that can promote human intestinal health, BON has built an international footprint with products sold across Asia, the U.S., and the EU. Its portfolio includes stachyose, apple polyphenols, broccoli extracts, and proprietary formulations like probiotic powder drinks and micro-eco repair shampoos.

About Bon Natural Life Limited (“BON”)

BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com.

文章來源:美聯社https://www.universalpressrelease.com/?pr=bon-announces-revolutionary-postbiotic-blood-sugar-solution-nears-patent-launch


推薦新聞

主站蜘蛛池模板: 97色伦图片97综合影院 | 白丝喷浆在线观看 | 国产奇特视频一二区 | 亚洲18 在线天美传媒 | 中文字幕国产精品 | 亚洲综合精品第一页 | 国产玉足脚交在线播放 | 日韩国产一区二区三区在线观看 | 91大家都在搜 | 91妇女色啪网站一区二区 | 真人一级性爱视频在线播放 | 精品国产高清免费在线观看 | 91秘 成人秘密入口导航 | 亚洲ⅴa国产日韩欧美精品 亚洲午夜精 | 91一区视频 | 青青在线视频 | 亚洲高清一区二区三区在线观看 | 91凤楼| 99国产精品一区二区毛卡片色戒 | 国产suv精品一区二区五 | 国产精品自在拍在线播放 | 香蕉天天人人精品欧美 | 日本一片二片三片 | 91啦丨九色丨刺激 中文 特色 | 日本不卡在线 | 亚洲成a人v欧美综合天 | 男女交性全过程 | 91国产精品 | 欧美激情一区二区三区不卡 | 亚洲精品伦理 | 日本一区二区三区精品道不卡 | 国产精品日韩欧美在线第3页 | 成人影片在线播放 | 91色人| www.奇米.com| 国产综合不卡 | 国产尤物视频 | 欧美 日韩 国产 一区 | 精品亚洲国产成v人片传媒 欧美黑人又粗又大又爽 | 欧美高清一区二区三区 | 最新偷拍家庭视频网2025年 |